Home
Resource
The antibacterial mode of action and properties of Ib-AMP1, a plant-derived antimicrobial peptide, against Escherichia coli O157:H7
PDF
PDF format is widely accepted and good for printing.
Plug-in required
PDF-1(1.98 MB)
Citation & Export
View Usage Statistics
Staff View

Citation & Export
Hide

Simple citation

Wu, Wen-Hsuan. The antibacterial mode of action and properties of Ib-AMP1, a plant-derived antimicrobial peptide, against Escherichia coli O157:H7. Retrieved from https://doi.org/doi:10.7282/T3RR1WTD

Export

Click here for information about Citation Management Tools at Rutgers.

Statistics
Hide

Description

TitleThe antibacterial mode of action and properties of Ib-AMP1, a plant-derived antimicrobial peptide, against Escherichia coli O157:H7
NameWu, Wen-Hsuan (author); Matthews, Karl R (chair); Di, Rong (co-chair); Chikindas, Mikhael L (internal member); Renye, John A (outside member); Rutgers University; Graduate School - New Brunswick
Date Created2013
Other Date2013-05 (degree)
SubjectFood Science, Antibacterial agents, Food industry and trade, Escherichia coli O157:H7, Food--Microbiology
Extentxiv, 158 p. : ill.
DescriptionThe continual occurrence of foodborne outbreaks along with the consumer demand for use of fewer traditional antimicrobial agents in foods has driven research interests in development of plant-derived antimicrobial agents (pAMPs) for use in food and food processing. Ib-AMP1 is a pAMP isolated from seeds of Impatiens balsamina. Previous studies indicated that it is a broad spectrum pAMP and the therapeutic index against eight human pathogens was 23.5; however, for future utilization, other antibacterial properties and mode of action must be elucidated. The purpose of this dissertation was to investigate the antibacterial properties and mode of action of Ib-AMP1 against Escherichia coli O157:H7, a foodborne pathogen that has been continually associated with foodborne outbreaks. The study design provided insight on the implantation and potential application of Ib-AMP1; a specific docking site or ligand-receptor relationship was not studied. The results demonstrated that Ib-AMP1 exhibited bactericidal activity against E. coli O157:H7, Salmonella enterica serovar Newport, Pseudomonas aeruginosa and Staphylococcus aureus. Ib-AMP1 at lethal concentrations (1X and 2X MIC) resulted in 1.46 to 2.69 log reduction of viable cells and prevented outgrowth when tested against low (103 CFU/mL) and medium (106 CFU/mL) E. coli O157:H7 populations. Ib-AMP1 at 2X MIC failed to inhibit and prevent outgrowth when cell numbers were 109 CFU/mL. No residual activity of Ib-AMP1 was apparent following interaction of the peptide with bacteria or the medium. Ib-AMP1 concentration less than 100 µg/mL showed little or no inhibition of human cell proliferation including human small intestine, colon and liver cells, which are associated with oral consumption of an AMP. The mode of action study demonstrated that a concentration dependent effect of Ib-AMP1 on the E. coli O157:H7 cell membrane occurred. Ib-AMP1 treatments resulted in efflux of K+ and ATP, suggesting pores of sufficient size to allow efflux of large molecules. The efflux of intracellular components may be associated with damage to the outer membrane and dissipation of cytoplasmic membrane potential. Results of this study suggest Ib-AMP1 is bactericidal interfering within outer and inner membrane integrity permitting efflux of ATP and interfering with intracellular biosynthesis of DNA, RNA, and protein.
NotePh.D.
NoteIncludes bibliographical references
NoteIncludes vita
Noteby Wen-Hsuan Wu
Genretheses, ETD doctoral
Persistent URLhttps://doi.org/doi:10.7282/T3RR1WTD
Languageeng
CollectionGraduate School - New Brunswick Electronic Theses and Dissertations
Organization NameRutgers, The State University of New Jersey
RightsThe author owns the copyright to this work.
Version 8.5.5
Rutgers University Libraries - Copyright ©2024